[Increased signal intensities and gadolinium levels in the brain after administration of gadolinium-based MR contrast agents : Clinical observations and results from preclinical research].

CONCLUSION: To date, no clinical symptoms have been confirmed to be associated with the increased signal intensity or gadolinium presence in the brain.
PMID: 30887087 [PubMed - as supplied by publisher]

Source: Der Radiologe - March 17, 2019 Category: Radiology Authors: Schöckel L, Balzer T, Pietsch H Tags: Radiologe Source Type: research